Department of Applied Tumor Biology, Institute of Pathology, Ruprecht Karls University of Heidelberg, Heidelberg, Germany.
J Low Genit Tract Dis. 2013 Jul;17(3):289-97. doi: 10.1097/LGT.0b013e31826f2b2b.
The incidence of vulvar squamous cell carcinomas located between the clitoris and urethra in young women is rising in distinct geographic regions, but characteristics of the tumors indicating certain carcinogenic mechanisms are unknown. The present study aimed at characterizing these vulvar cancers for their human papillomavirus (HPV), p16(INK4a), and p53 status, revealing potential pathways of carcinogenesis.
Squamous cell vulvar cancers of the anterior fourchette were retrospectively collected from 8 German hospitals, with additional squamous cell cancers located at other sites of the vulva from 2 of the hospitals. All tumors were analyzed for HPV DNA by polymerase chain reaction and for p16(INK4a) and p53 expression by immunohistochemistry.
Potentially HPV-associated tumors (HPV and p16(INK4a) positive, 21.4% [27/126] of the anterior fourchette and 27.7% [13/47] from other locations), p53-overexpressing tumors (35.7% [45/126] and 29.8% [14/47]), and a third group (HPV/p16(INK4a) negative/p53 not overexpressed, 42.9% [54/126] and 42.6% [20/47]) were observed among tumors from the anterior fourchette as well as among vulvar cancers from other locations. Women with vulvar cancers of the anterior fourchette were of young age irrespective of the HPV/p16(INK4a)/p53 status.
Different types of vulvar cancers can be found in squamous cell tumors of the anterior fourchette, similar to the finding in vulvar cancers from other locations and to what has previously been reported for vulvar squamous cell carcinomas in general.
在特定地理区域,年轻女性阴蒂和尿道之间的外阴鳞状细胞癌发病率正在上升,但表明某些致癌机制的肿瘤特征尚不清楚。本研究旨在对这些外阴癌进行人乳头瘤病毒(HPV)、p16(INK4a)和 p53 状态分析,揭示潜在的致癌途径。
回顾性收集来自 8 家德国医院的前阴阜部位的鳞状细胞外阴癌,并从其中 2 家医院的其他外阴部位收集额外的鳞状细胞癌。所有肿瘤均通过聚合酶链反应分析 HPV DNA,通过免疫组织化学分析 p16(INK4a)和 p53 表达。
潜在 HPV 相关肿瘤(HPV 和 p16(INK4a)阳性,前阴阜的 21.4%[27/126]和其他部位的 27.7%[13/47])、p53 过表达肿瘤(35.7%[45/126]和 29.8%[14/47])和第三组(HPV/p16(INK4a)阴性/p53 不过表达,前阴阜的 42.9%[54/126]和其他部位的 42.6%[20/47])在阴阜部位的肿瘤以及其他部位的外阴癌中均有观察到。无论 HPV/p16(INK4a)/p53 状态如何,前阴阜外阴癌患者均为年轻女性。
在阴阜的鳞状细胞肿瘤中可以发现不同类型的外阴癌,这与其他部位的外阴癌以及普遍报道的外阴鳞状细胞癌的发现相似。